October 15, 2026

Trump Administration Moves to Allow Peptide Drug Production

Health Secretary Robert F. Kennedy Jr. submitted a plan to the White House for review.
The policy would allow compounding pharmacies to produce certain unregulated peptides like BPC-157.
FDA previously deemed these peptides too risky for compounding due to potential health risks.

Read the news this way every day.

Concur organizes political reporting into clear stories and shows the sources behind each one.

Free. No ads.